dcp-001
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 15, 2018 (NCT03697707)
Timeline
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04739527 | Phase 1 | Mar 1, 2021 | DCPrime BV, University of Groningen |
| NCT03697707 | Phase 2 | Oct 15, 2018 | DCPrime BV, Free University of Amsterdam |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| DCPrime BV | For profit | 2 | 1 | 2 | 2018 |
| Free University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2018 |
| University of Groningen | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1